phrykt

HCA Healthcare, Inc. (HCA): who owns it and who trades it

As of Nov 16, 2026, HCA insiders reported 22 open-market sales worth $47.5M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Samuel N Hazen (CEO), with $21.5M. 10 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling HCA Healthcare

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Congress mostly bought. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns HCA

1,335 funds and institutions reported HCA shares worth $52.9B at the end of Q2 2026, about 61% of the company. The largest holder is BlackRock, Inc. with 5.9%.

Funds and institutions (13F) 61%Everyone else 39%

10 largest owners, by share of the company

BlackRock, Inc.5.9%
Vanguard Capital Management LLC4.6%
Sanders Capital, LLC4.0%
State Street Corp3.4%
First Eagle Investment Management, LLC3.0%
Wellington Management Group LLP2.1%
Geode Capital Management, LLC1.7%
Vanguard Portfolio Management LLC1.2%
Morgan Stanley1.2%
Goldman Sachs Group Inc1.1%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.13.00M5.86%$5.1B-3%
Vanguard Capital Management LLC10.14M4.57%$4B-0%
Sanders Capital, LLC8.83M3.98%$3.4B-1%
State Street Corp7.47M3.37%$2.9B-1%
First Eagle Investment Management, LLC6.59M2.97%$2.6B+103%
Wellington Management Group LLP4.71M2.12%$1.8B+20%
Geode Capital Management, LLC3.67M1.65%$1.4B-1%
Vanguard Portfolio Management LLC2.71M1.22%$1.1B-2%
Morgan Stanley2.59M1.17%$1B+13%
Goldman Sachs Group Inc2.46M1.11%$961M+15%
JPMorgan Chase & Co2.29M1.03%$897M–
Arrowstreet Capital, Limited Partnership2.21M1.00%$861M+2%
Norges Bank2.15M0.97%$836M–
Capital World Investors1.98M0.89%$771M+0%
Capital International Investors1.92M0.86%$747M-37%
Northern Trust Corp1.71M0.77%$666M-2%
FMR LLC (Fidelity)1.63M0.74%$637M-63%
Invesco Ltd.1.53M0.69%$596M+6%
Nordea Investment Management AB1.43M0.64%$554M-1%
Barclays PLC1.32M0.59%$514M+6%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, HCA insiders reported $0 of open-market purchases and $47.5M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$47.5M
22 trades, 8 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Nov 10, 2026
Filed Nov 10, 2026

Purchases and sales by month

$29.3M$29.3MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 10, 2026Erica RossittoVice presidentSale3,500$505.81$1.8MForm 4
Nov 6, 2026Jon M FosterVice presidentSale890$498.97$444KForm 4
Nov 6, 2026Jon M FosterVice presidentSale1,684$498.00$839KForm 4
Nov 6, 2026Jon M FosterVice presidentSale1,066$496.92$530KForm 4
Nov 6, 2026Jon M FosterVice presidentSale2,692$495.85$1.3MForm 4
Nov 6, 2026Jon M FosterVice presidentSale7,595$494.91$3.8MForm 4
Nov 6, 2026Jon M FosterVice presidentSale6,302$493.58$3.1MForm 4
Nov 6, 2026Jon M FosterVice presidentSale1,484$491.98$730KForm 4
Nov 4, 2026Jon M FosterVice presidentSale10,000$514.07$5.1MForm 4
Nov 4, 2026Michael J SchlosserVice presidentSale1,200$494.65$594KForm 4
Feb 18, 2026Michael R McAleveyVice presidentSale1,694$533.37$904KForm 4
Feb 11, 2026Christopher F. WyattVice presidentSale4,000$505.00$2MForm 4
Feb 11, 2026Jennifer BerresVice presidentSale4,010$526.16$2.1MForm 4
Feb 11, 2026Jennifer BerresVice presidentSale4,010$503.00$2MForm 4
Feb 3, 2026Samuel N HazenCEOSale14,716$502.95$7.4MForm 4
Feb 3, 2026Samuel N HazenCEOSale5,002$502.15$2.5MForm 4
Feb 3, 2026Samuel N HazenCEOSale7,395$500.69$3.7MForm 4
Feb 3, 2026Samuel N HazenCEOSale6,189$500.02$3.1MForm 4
Feb 3, 2026Samuel N HazenCEOSale5,162$498.80$2.6MForm 4
Feb 3, 2026Samuel N HazenCEOSale4,293$498.12$2.1MForm 4
Feb 3, 2026Samuel N HazenCEOSale120$497.18$59.7KForm 4
Feb 3, 2026Michael S. CuffeVice presidentSale1,500$498.09$747KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Samuel N HazenCEO, Director–$21.5MFeb 3, 2026
Jon M FosterEVP and COO–$15.9MNov 6, 2026
Jennifer BerresSVP & Chief Human Res. Officer–$4.1MFeb 11, 2026
Christopher F. WyattSVP & Controller–$2MFeb 11, 2026
Erica RossittoSVP & Chief Nurse Executive–$1.8MNov 10, 2026
Michael R McAleveyEVP & Chief Legal & Admin Off.–$904KFeb 18, 2026
Michael S. CuffeEVP and Chief Clinical Officer–$747KFeb 3, 2026
Michael J SchlosserEVP and Chief Clinical Officer–$594KNov 4, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

HCA short interest

Low short interest. 2.3% of HCA shares are sold short: about 1 share in 44. Over the last 12 reports the number of shares short went up 8%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 4.80M HCA shares were sold short, 2.3% of the shares outstanding, down 2.1% from the report before. At the average daily volume of 1.45M shares, buying them all back would take about 3.3 trading days (days to cover).

Shares short, % of all shares

2.30%May 15Oct 303.14%

Days to cover

3.3May 15Oct 306.0

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20264.80M2.30%-2%1.45M3.3
Oct 15, 20264.91M2.27%+0%1.07M4.6
Sep 30, 20264.88M2.26%-25%1.59M3.1
Sep 15, 20266.48M2.99%+6%1.43M4.5
Aug 31, 20266.14M2.83%+0%1.25M4.9
Aug 14, 20266.13M2.83%+1%1.10M5.6
Jul 31, 20266.06M2.80%+4%1.72M3.5
Jul 15, 20265.83M2.63%+9%1.86M3.1
Jun 30, 20265.35M2.41%+3%1.54M3.5
Jun 15, 20265.21M2.35%No change1.93M2.7
May 29, 20265.21M2.35%+17%1.76M3.0
May 15, 20264.45M2.01%+3%1.23M3.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded HCA

Since Nov 17, 2024, 6 members of Congress reported 6 purchases and 4 sales of HCA. The latest was a purchase by Jared Moskowitz on Jun 17, 2026, reported Jul 26, 2026.

Purchases 6Sales 4

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Jun 17, 2026Jared Moskowitz (D-FL)Purchase$1K–$15KChildJul 26, 2026Report
Jun 17, 2026Jared Moskowitz (D-FL)Purchase$1K–$15KSelfJul 26, 2026Report
Mar 27, 2026Alan Armstrong (R-OK)Purchase$1K–$15KSelfJul 21, 2026Report
Sep 11, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseOct 22, 2025Report
Aug 19, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseSep 12, 2025Report
May 15, 2025Jared Moskowitz (D-FL)Purchase$1K–$15KSelfJun 27, 2025Report
May 15, 2025Jared Moskowitz (D-FL)Purchase$1K–$15KChildJun 27, 2025Report
Apr 7, 2025Julie Johnson (D-TX)Sale$1K–$15KJointMay 14, 2025Report
Feb 25, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$1K–$15KSelfMar 27, 2025Report
Dec 27, 2024Val T. Hoyle (D-OR)Sale$1K–$15KSpouseSep 12, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

HCA Healthcare company events

HCA Healthcare filed 13 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 5, 2026.

  1. Nov 5, 2026AgreementHCA Inc., a direct, wholly owned subsidiary of HCA Healthcare, Inc., completed the public offering of (i) $500 million of its 5.200% Senior Notes due 2028, (ii) $300 million of its Floating Rate Senior Notes due 2028, (iii) $1 billion of its 5.350% Senior Notes due 2029, (iv) $1.25 billion of its… Filing
  2. Nov 2, 2026AnnouncementHCA Healthcare, Inc. issued a press release announcing the commencement of its proposed public offering by HCA Inc., a direct, wholly owned subsidiary of the Registrant, of senior unsecured notes. Filing
  3. Oct 27, 2026AnnouncementThe Company announced that its Board of Directors had declared a quarterly cash dividend of $0.78 per share of the Company’s common stock. Filing
  4. Jul 29, 2026AnnouncementBelow is incorporated by reference into this Item 2.03. Filing
  5. Jul 24, 2026AnnouncementThe Company announced that its Board of Directors had declared a quarterly cash dividend of $0.78 per share of the Company’s common stock. Filing
  6. Jul 14, 2026ResultsReleased financial results. Filing
  7. Jun 18, 2026LeadershipDr. Michael Cuffe and HCA Healthcare, Inc. agreed that Dr. Cuffe will step down as Executive Vice President and Chief Clinical Officer effective August 31, 2026, and thereafter continue in a transitional role with the Company until February 2027. Filing
  8. Apr 30, 2026AgreementHCA Inc., a direct, wholly owned subsidiary of HCA Healthcare, Inc., completed the public offering of (i) $1 billion of its 4.700% Senior Notes due 2031, (ii) $750 million of its 5.000% Senior Notes due 2033 and (iii) $1.25 billion of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together… Filing
  9. Apr 28, 2026VoteReported shareholder vote results. Filing
  10. Apr 27, 2026AnnouncementHCA Healthcare, Inc. issued a press release announcing the commencement of its proposed public offering by HCA Inc., a direct, wholly owned subsidiary of the Registrant, of senior unsecured notes. Filing
  11. Apr 24, 2026AnnouncementThe Company announced that its Board of Directors had declared a quarterly cash dividend of $0.78 per share of the Company’s common stock. Filing
  12. Feb 25, 2026LeadershipThe Compensation Committee of the Board of Directors of HCA Healthcare, Inc. adopted the 2026 Executive Officer Performance Excellence Program. Filing
  13. Jan 27, 2026AnnouncementThe Company announced that its Board of Directors had authorized an additional share repurchase program for up to $10 billion of the Company’s outstanding common stock. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

HCA Healthcare financials

Famous investors that hold HCA

10 of the 50 well-known investors we track reported holding HCA in their latest 13F filing. The largest position is Ray Dalio's, worth $86.3M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ray Dalio · Bridgewater AssociatesQ3 2026202,141$86.3M0.4%-1%
Israel Englander · Millennium ManagementQ3 2026165,181$70.5M0.1%+158%
Bill Nygren · Harris Associates (Oakmark)Q3 2026152,896$65.2M0.1%-1%
Ken Griffin · Citadel AdvisorsQ3 2026102,951$43.9M0.0%-44%
Richard Pzena · Pzena Investment ManagementQ3 202699,648$42.5M0.1%+3%
Tom Gayner · Markel GroupQ3 202684,972$36.3M0.3%+1%
Paul Tudor Jones · Tudor Investment CorpQ3 20266,380$2.7M0.0%New
Glenn Greenberg · Brave Warrior AdvisorsQ3 20264,666$2M0.0%-3%
Lee Ainslie · Maverick CapitalQ3 20263,319$1.4M0.0%New
Ken Fisher · Fisher Asset ManagementQ3 20262,491$1.1M0.0%-17%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named HCA in the last 120 days.

FiledHolderFormStake
Nov 6, 2026Frisco Holding II13D/A18.6%
Nov 6, 2026Frisco Holding II13D/A18.6%

Questions about HCA Healthcare, Inc. (HCA) stock

Who owns the most HCA stock?

The largest reported owner of HCA Healthcare, Inc. (HCA) is BlackRock, Inc., with 5.9% of the company. In total, 1,335 funds and institutions reported holding HCA at the end of Q2 2026, together about 61% of the shares. See the largest owners.

Are HCA insiders buying or selling?

In the last 12 months, HCA insiders reported no open-market purchases and 22 sales worth $47.5M. The latest trade was on Nov 10, 2026. See every trade.

What is the short interest in HCA?

As of Oct 30, 2026, 4.80M HCA shares were sold short, 2.3% of the shares outstanding, down 2.1% from the report before. At the average daily volume of 1.45M shares, buying them all back would take about 3.3 trading days (days to cover). See the history.

Have members of Congress traded HCA?

Yes. 6 members of Congress reported 6 purchases and 4 sales of HCA since Nov 17, 2024. The latest was reported on Jul 26, 2026. See the trades.

Which famous investors hold HCA?

10 of the 50 well-known investors we track reported HCA in their latest 13F filing, including Ray Dalio, Israel Englander, Bill Nygren. The largest position is worth $86.3M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.